AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Gross intangible assets cost by Year
Gross intangible assets cost ($M) ($M)
AstraZeneca Gross intangible assets cost: $82,940M in FY2025, up 7.8% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
82,940
Period ended Dec 31, 2025
Change on a year earlier
+7.8%
76,913 in FY2024
History
8 years
Since FY2018
Sources
4
Documents cited below
Where the FY2025 figure comes from
Reported in Form 20-F Note 10 — Intangible Assets (Inline XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Gross intangible assets cost ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 82,940 | +7.8% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 76,913 | +4.7% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 73,489 | +4.1% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 70,622 | 0.0% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 70,633 | +51.6% | Form 20-F FY2024 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 46,607 | +3.4% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 45,084 | +3.6% | Form 20-F FY2023 Annual Report ↗ |
| FY2018 | Dec 31, 2018 | 43,501 | – | Form 20-F FY2022 Annual Report ↗ |
Cite this data
StockData. (2026). AstraZeneca Gross intangible assets cost ($M), annual FY2018–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/intang-gross-total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.